Flossbach Von Storch’s Bristol-Myers Squibb BMY Stock Holding History

Flossbach Von Storch’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,465	Closed	-$699K	–	113
2025 Q1	$699K	Buy	+11,465	New	+$668K	﹤0.01%	108
2020 Q4	–	Sell	-3,720	Closed	-$224K	–	94
2020 Q3	$224K	Sell	3,720 -1,640	-31%	-$98.7K	﹤0.01%	90
2020 Q2	$315K	Hold	5,360	–	–	﹤0.01%	94
2020 Q1	$299K	Hold	5,360	–	–	﹤0.01%	101
2019 Q4	$344K	Hold	5,360	–	–	﹤0.01%	102
2019 Q3	$272K	Buy	+5,360	New	+$252K	﹤0.01%	96

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Flossbach Von Storch's BMY Position: Q2 2025 in Review

Flossbach Von Storch sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 11,465 shares — an estimated $699K sold.

Flossbach Von Storch first reported a position in BMY in Q3 2019 and held it in 6 quarters. The position peaked at $699K in Q1 2025. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Flossbach Von Storch reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Flossbach Von Storch sold 11,465 Bristol-Myers Squibb shares in Q2 2025, an estimated $699K.
Flossbach Von Storch first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 6 quarters.
Flossbach Von Storch's Bristol-Myers Squibb position peaked at $699K in Q1 2025.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Flossbach Von Storch's 13F filing for Q2 2025, filed 7 Aug 2025.